Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 35 most recent Form 4 transactions.
| Aug 12 | SUPN | Supernus Pharmaceuticals,… | MEXER | 1,650 | — | — | +8.8% | Open the original filing on SEC.gov |
| Jul 29 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 1,650 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | SUPN | Supernus Pharmaceuticals,… | SSELL | 1,623 | $53.65 | $87.1K | -8.1% | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 3,750 | — | — | — | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | FTAX | 1,793 | $54.73 | $98.1K | -8.2% | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | MEXER | 3,750 | — | — | +20.7% | Open the original filing on SEC.gov |
| Feb 28 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 3,750 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 1,875 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | SUPN | Supernus Pharmaceuticals,… | FTAX | 977 | $50.69 | $49.5K | -5.1% | Open the original filing on SEC.gov |
| Feb 25 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 1,875 | — | — | +10.9% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 1,250 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 750 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 1,125 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | FTAX | 670 | $50.86 | $34.1K | -3.8% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 1,250 | — | — | +7.5% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | FTAX | 368 | $50.86 | $18.7K | -2.2% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 750 | — | — | +4.6% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | FTAX | 603 | $51.35 | $31K | -3.6% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 1,125 | — | — | +7.1% | Open the original filing on SEC.gov |
| Feb 18 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 18 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 13,500 | — | — | — | Open the original filing on SEC.gov |
| Dec 19, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 19, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 19, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 15,000 | $50.47 | $757.1K | -49.2% | Open the original filing on SEC.gov |
| Dec 19, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 15,000 | $25.30 | $379.5K | +96.8% | Open the original filing on SEC.gov |
| Dec 19, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 5,000 | $50.22 | $251.1K | -24.4% | Open the original filing on SEC.gov |
| Dec 19, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 5,000 | $39.40 | $197K | +32.3% | Open the original filing on SEC.gov |
| Sep 12, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 12, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL | 5,000 | $45.87 | $229.4K | -24.4% | Open the original filing on SEC.gov |
| Sep 12, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER | 5,000 | $39.40 | $197K | +32.3% | Open the original filing on SEC.gov |
| Aug 25, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 14,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 25, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL | 14,000 | $44.51 | $623.1K | -47.5% | Open the original filing on SEC.gov |
| Aug 25, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER | 14,000 | $12.98 | $181.7K | +90.3% | Open the original filing on SEC.gov |